158 related articles for article (PubMed ID: 2805618)
1. Tolerability and efficacy of oral chrysotherapy in patients with Sjögren's syndrome secondary to rheumatoid arthritis (SS-RA).
Mathieu A; Pala R; Nurchis P; Contu L
Clin Rheumatol; 1989 Sep; 8(3):413-6. PubMed ID: 2805618
[No Abstract] [Full Text] [Related]
2. Effectiveness of abatacept for patients with Sjögren's syndrome associated with rheumatoid arthritis. An open label, multicenter, one-year, prospective study: ROSE (Rheumatoid Arthritis with Orencia Trial toward Sjögren's syndrome Endocrinopathy) trial.
Tsuboi H; Matsumoto I; Hagiwara S; Hirota T; Takahashi H; Ebe H; Yokosawa M; Yagishita M; Takahashi H; Kurata I; Ohyama A; Honda F; Asashima H; Miki H; Umeda N; Kondo Y; Hirata S; Saito K; Tanaka Y; Horai Y; Nakamura H; Kawakami A; Sumida T
Mod Rheumatol; 2016 Nov; 26(6):891-899. PubMed ID: 27459020
[TBL] [Abstract][Full Text] [Related]
3. Secondary Sjögren's syndrome and disease activity of rheumatoid arthritis.
Antero DC; Parra AG; Miyazaki FH; Gehlen M; Skare TL
Rev Assoc Med Bras (1992); 2011; 57(3):319-22. PubMed ID: 21691696
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of abatacept for patients with Sjögren's syndrome associated with rheumatoid arthritis: rheumatoid arthritis with orencia trial toward Sjögren's syndrome Endocrinopathy (ROSE) trial-an open-label, one-year, prospective study-Interim analysis of 32 patients for 24 weeks.
Tsuboi H; Matsumoto I; Hagiwara S; Hirota T; Takahashi H; Ebe H; Yokosawa M; Hagiya C; Asashima H; Takai C; Miki H; Umeda N; Kondo Y; Ogishima H; Suzuki T; Hirata S; Saito K; Tanaka Y; Horai Y; Nakamura H; Kawakami A; Sumida T
Mod Rheumatol; 2015 Mar; 25(2):187-93. PubMed ID: 25211401
[TBL] [Abstract][Full Text] [Related]
5. [Initial experience using protease inhibitors in treating Sjögren's disease and syndrome].
Matveĭkov GP; Soroka NF; Paliĭ LI
Revmatologiia (Mosk); 1985; (3):50-3. PubMed ID: 3903933
[No Abstract] [Full Text] [Related]
6. Infliximab therapy in patients with secondary Sjögren's syndrome: functional evaluation.
Martin Martin LS; Migliore A; Todino V; Pagano A; Chianelli M
Clin Exp Rheumatol; 2003; 21(3):412. PubMed ID: 12846076
[No Abstract] [Full Text] [Related]
7. Natural cell-mediated cytotoxicity in Sjögren's syndrome and rheumatoid arthritis.
Goto M; Tanimoto K; Chihara T; Horiuchi Y
Arthritis Rheum; 1981 Nov; 24(11):1377-82. PubMed ID: 7317114
[TBL] [Abstract][Full Text] [Related]
8. Nephrocalcinosis in a patient with rheumatoid arthritis and secondary Sjögren's syndrome.
Jiménez Liñán LM; Rodríguez Montero SA; Marenco de la Fuente JL
Reumatol Clin (Engl Ed); 2019; 15(1):58-59. PubMed ID: 28359765
[No Abstract] [Full Text] [Related]
9. [Sjögren's syndrome in the course of rheumatoid arthritis].
Miko M; Bruck S; Vidović K; Separovic V
Reumatizam; 1975; 22(5):182-8. PubMed ID: 1197951
[No Abstract] [Full Text] [Related]
10. Sjogren's syndrome and the sicca syndrome: the role of prostaglandin E1 deficiency. Treatment with essential fatty acids and vitamin C.
Horrobin DF; Campbell A
Med Hypotheses; 1980 Mar; 6(3):225-32. PubMed ID: 7432243
[TBL] [Abstract][Full Text] [Related]
11. Clinical characteristics and risk factors for overlapping rheumatoid arthritis and Sjögren's syndrome.
Yang H; Bian S; Chen H; Wang L; Zhao L; Zhang X; Zhao Y; Zeng X; Zhang F
Sci Rep; 2018 Apr; 8(1):6180. PubMed ID: 29670135
[TBL] [Abstract][Full Text] [Related]
12. [A case of rheumatoid arthritis with systemic lupus erythematosus, Sjögren's syndrome and Crohn's disease].
Fujimori J; Yoshino S; Morishige T; Kishimoto M; Suzuki N; Ohba H
Ryumachi; 1987 Aug; 27(4):294-300. PubMed ID: 3448786
[No Abstract] [Full Text] [Related]
13. [Rheumatoid factor, subcutaneous nodules and Sjogren's syndrome in rheumatoid polyarthritis in Magreb].
Hamza M; Bardi R
Rev Rhum Ed Fr; 1993; 60(7-8):546-7. PubMed ID: 8148861
[No Abstract] [Full Text] [Related]
14. Raised C-reactive protein response in rheumatoid arthritis patients with secondary Sjögren's syndrome.
Youinou P; Fauquert P; Pennec YL; Bendaoud B; Katsikis P; Le Goff P
Rheumatol Int; 1990; 10(1):39-41. PubMed ID: 2353152
[TBL] [Abstract][Full Text] [Related]
15. Etanercept in Sjögren's syndrome: a twelve-week randomized, double-blind, placebo-controlled pilot clinical trial.
Sankar V; Brennan MT; Kok MR; Leakan RA; Smith JA; Manny J; Baum BJ; Pillemer SR
Arthritis Rheum; 2004 Jul; 50(7):2240-5. PubMed ID: 15248223
[TBL] [Abstract][Full Text] [Related]
16. [Hypereosinophilia in Sjögren's syndrome].
Trofimov GA; Minaeva IN
Klin Med (Mosk); 1987 Jun; 65(6):126-8. PubMed ID: 3626447
[No Abstract] [Full Text] [Related]
17. Epstein-Barr virus, methotrexate, and lymphoma in patients with rheumatoid arthritis and primary Sjögren's syndrome: case series.
Dawson TM; Starkebaum G; Wood BL; Willkens RF; Gown AM
J Rheumatol; 2001 Jan; 28(1):47-53. PubMed ID: 11196542
[TBL] [Abstract][Full Text] [Related]
18. [Extra-articular manifestations of rheumatoid arthritis].
Tao XL; Dong Y; Zhu YJ
Zhonghua Nei Ke Za Zhi; 1987 Jun; 26(6):348-50, 381. PubMed ID: 3652842
[No Abstract] [Full Text] [Related]
19. Sjögren's syndrome associated with erosive rheumatoid arthritis alters its prognosis and long-term therapeutic response: a case-control study.
Laroche M; Degboe Y; Constantin A
Rheumatol Int; 2023 Feb; 43(2):363-366. PubMed ID: 34999915
[TBL] [Abstract][Full Text] [Related]
20. Ankylosing spondylitis with subsequent development of rheumatoid arthritis, Sjögren's syndrome, and rheumatoid vasculitis.
Clayman MD; Reinertsen JL
Arthritis Rheum; 1978 Apr; 21(3):383-9. PubMed ID: 646836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
